<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>A "shotgun" lipidomics strategy consisting of sequential functional group selective chemical modification reactions coupled with high-resolution/accurate mass spectrometry and "targeted" tandem mass spectrometry (MS/MS) analysis has been developed and applied toward the comprehensive identification, characterization and quantitative analysis of changes in relative abundances of &gt;600 individual <z:chebi fb="0" ids="37739">glycerophospholipid</z:chebi>, <z:chebi fb="0" ids="35741">glycerolipid</z:chebi>, <z:chebi fb="0" ids="26739">sphingolipid</z:chebi> and <z:chebi fb="0" ids="15889">sterol</z:chebi> <z:chebi fb="23" ids="18059">lipids</z:chebi> between a primary <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>) cell line, SW480, and its isogenic lymph node metastasized derivative, SW620 </plain></SENT>
<SENT sid="1" pm="."><plain>Selective chemical derivatization of <z:chebi fb="0" ids="36314">glycerophosphoethanolamine</z:chebi> and <z:chebi fb="0" ids="35766">glycerophosphoserine</z:chebi> <z:chebi fb="23" ids="18059">lipids</z:chebi> using a "fixed charge" <z:chebi fb="0" ids="30488">sulfonium</z:chebi> ion containing, d(6)-S,S'-dimethylthiobutanoylhydroxysuccinimide <z:chebi fb="21" ids="35701">ester</z:chebi> (d(6)-DMBNHS) reagent was used to eliminate the possibility of isobaric mass overlap of these species with the precursor ions of <z:hpo ids='HP_0000001'>all</z:hpo> other <z:chebi fb="23" ids="18059">lipids</z:chebi> in the crude extracts, thereby enabling their unambiguous assignment, while subsequent selective mild acid hydrolysis of plasmenyl (vinyl-<z:chebi fb="91" ids="25698">ether</z:chebi>) containing <z:chebi fb="23" ids="18059">lipids</z:chebi> using <z:chebi fb="3" ids="30751">formic acid</z:chebi> enabled these species to be readily differentiated from isobaric mass plasmanyl (alkyl-<z:chebi fb="91" ids="25698">ether</z:chebi>) containing <z:chebi fb="23" ids="18059">lipids</z:chebi> </plain></SENT>
<SENT sid="2" pm="."><plain>Using this approach, statistically significant differences in the abundances of numerous <z:chebi fb="23" ids="18059">lipid</z:chebi> species previously identified as being associated with <z:e sem="disease" ids="C0178874" disease_type="Neoplastic Process" abbrv="">cancer progression</z:e> or that play known roles as mediators in a range of physiological and pathological processes were observed between the SW480 and SW620 cells </plain></SENT>
<SENT sid="3" pm="."><plain>Most notably, these included increased plasmanylcholine and <z:chebi fb="0" ids="17855">triglyceride</z:chebi> <z:chebi fb="23" ids="18059">lipid</z:chebi> levels, decreased plasmenylethanolamine <z:chebi fb="23" ids="18059">lipids</z:chebi>, decreased C-16 containing <z:chebi fb="0" ids="17636">sphingomyelin</z:chebi> and <z:chebi fb="7" ids="17761">ceramide</z:chebi> <z:chebi fb="23" ids="18059">lipid</z:chebi> levels, and a dramatic increase in the abundances of total <z:chebi fb="0" ids="17002">cholesterol ester</z:chebi> and <z:chebi fb="0" ids="17855">triglyceride</z:chebi> <z:chebi fb="23" ids="18059">lipids</z:chebi> in the SW620 cells compared to those in the SW480 cells </plain></SENT>
</text></document>